Aln-Ttrsc02

Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)

Alnylam PharmaceuticalsPhase 1

—

Rating in progress

Aln-Ttrsc02 in Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant